Aptagen, LLC
GL21.T (ID# 9015)
RNA
Axl
Protein
12 nM (reported value)
filter binding analysis with the soluble extracellular domain of human Axl, Dtk, and Mer as targets (R&D Systems, Minneapolis, MN), was performed by incubating 1 nmol/l of radiolabeled aptamers with 1, 3.2, 10, 32, 100, 320, and 1,000 nmol/l of EC-Axl, EC-Dtk, or EC-Mer
37°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
rAprUprGprAprUprCprAprAprUprCprGprCprCprUprCprAprAprUprUprCprGprAprCprAprGprGprAprGprGprCprUprCprAprCp
34
10297.6 g/mole
319300 L/(mole·cm)
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Cerchia L, Esposito CL, Camorani S, Rienzo A, Stasio L, Insabato L, Affuso A, de Franciscis V. Targeting Axl with an high-affinity inhibitory aptamer. Mol Ther. 2012 Dec;20(12):2291-303. doi: 10.1038/mt.2012.163. Epub 2012 Aug 21. PMID: 22910292; PMCID: PMC3519989.
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.